Tuberculosis in children: considerations for children from developing countries

Lisa J Nelson1, Charles D Wells

  • 1Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA. lbn9@cdc.gov

Insights

Tuberculosis (TB) remains a global health threat, particularly for children in low-income nations and minority groups. Diagnosis and management require careful clinical evaluation and updated treatment strategies.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Tuberculosis (TB) is a leading infectious cause of illness and death globally.
  • While TB rates have decreased in US children, they persist in low-income countries and among minority populations.
  • Accurate pediatric TB data are limited, complicating diagnosis and management.

Purpose of the Study:

  • To summarize current understanding and management of pediatric tuberculosis.
  • To highlight challenges in diagnosing TB in children.
  • To emphasize the importance of updated treatment guidelines and public health interventions.

Main Methods:

  • Review of recent national and international treatment guidelines for pediatric TB.
  • Analysis of epidemiological trends in pediatric TB cases.
  • Discussion of diagnostic challenges, including clinical, historical, and bacteriological factors.

Main Results:

  • Pediatric TB case rates show disparities based on socioeconomic status and ethnicity.
  • Diagnosis in children often relies on a combination of clinical signs, patient history, and laboratory tests.
  • New treatment recommendations and management strategies have been published.

Conclusions:

  • Effective management of pediatric TB necessitates a comprehensive approach.
  • Contact investigation and directly observed therapy are crucial for optimal TB control in children.
  • Continued efforts are needed to improve data collection and diagnostic accuracy for childhood TB.

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories: